YU36693A - Derivati eritromicina - Google Patents

Derivati eritromicina

Info

Publication number
YU36693A
YU36693A YU36693A YU36693A YU36693A YU 36693 A YU36693 A YU 36693A YU 36693 A YU36693 A YU 36693A YU 36693 A YU36693 A YU 36693A YU 36693 A YU36693 A YU 36693A
Authority
YU
Yugoslavia
Prior art keywords
hydrogen atom
group
lower alkyl
erythromycin derivatives
atom
Prior art date
Application number
YU36693A
Other languages
English (en)
Other versions
YU48771B (sh
Inventor
H. Koga
T. Sato
H. Takanashi
Original Assignee
Chugai Seiyuaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyuaku Kabushiki Kaisha filed Critical Chugai Seiyuaku Kabushiki Kaisha
Publication of YU36693A publication Critical patent/YU36693A/sh
Publication of YU48771B publication Critical patent/YU48771B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DERIVATI ERITROMICINA, jedinjenje predstavljeno opštom formulom gde R1 je atom vodonika ili acil grupa, R2 i R3 mogu biti isti ili različiti i svaki je atom vodonika, acil, aciloksi ili amino grupa ili zajedno grade =O ili =NDR10 gde R10 je atom vodonika ili niža alkil grupa, R4 je atom vodonika ili niža alkil grupa i Y predstavlja -NR5R6 ili -N+R7R8R9X-, gde R5, R6, R7, R8 i R9 mogu biti isti ili različiti i svaki je atom vodonika ili niža alkil, alkenil ili alkinil grupa koja može biti supstituisana ili 3-7člana cikloalkil grupa koja može da sadrži atom kiseonika, azota ili sumpora kao heteroatom i X predstavlja anjom, gde R5 i R6 i R7 i R8 mogu da grade azacikloalkil grupu zajedno sa susednim atomom azota, i njihove soli. Ova jedinjenja i njihove soli u znatno manjem stepenu podležu razlaganju pod dejstvom stomačne kiseline od dosada poznatih derivata eritromicina i poseduju izvanredno enterolikinezi stimulišući dejstvo.
YU36693A 1992-05-26 1993-05-25 Derivati eritromicina YU48771B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13382892 1992-05-26

Publications (2)

Publication Number Publication Date
YU36693A true YU36693A (sh) 1996-07-24
YU48771B YU48771B (sh) 1999-12-27

Family

ID=15113997

Family Applications (1)

Application Number Title Priority Date Filing Date
YU36693A YU48771B (sh) 1992-05-26 1993-05-25 Derivati eritromicina

Country Status (21)

Country Link
US (1) US5658888A (sh)
EP (1) EP0643068B1 (sh)
JP (1) JP3068367B2 (sh)
KR (1) KR100226311B1 (sh)
CN (1) CN1036199C (sh)
AT (1) ATE169927T1 (sh)
AU (1) AU659740B2 (sh)
CA (1) CA2117883C (sh)
DE (1) DE69320476T2 (sh)
DK (1) DK0643068T3 (sh)
ES (1) ES2120499T3 (sh)
HK (1) HK1009969A1 (sh)
HR (1) HRP930926B1 (sh)
IL (1) IL105810A (sh)
MY (1) MY113693A (sh)
SG (1) SG52785A1 (sh)
SI (1) SI9300281B (sh)
TW (1) TW240230B (sh)
WO (1) WO1993024509A1 (sh)
YU (1) YU48771B (sh)
ZA (1) ZA933679B (sh)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007204490A (ja) * 1995-08-03 2007-08-16 Chugai Pharmaceut Co Ltd エリスロマイシン誘導体の製造方法
ZA966601B (en) * 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
US6077943A (en) * 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
AU3634397A (en) * 1996-07-24 1998-02-10 Chugai Seiyaku Kabushiki Kaisha Erythromycin derivatives
US6100239A (en) * 1996-11-26 2000-08-08 Chugai Seiyaku Kabushiki Kaisha 13-membered ring macrolide compound, medicine containing the same, and process for producing the same
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
CA2399198A1 (en) 2000-02-18 2001-08-23 Christopher Carreras Motilide compounds
AU8257701A (en) 2000-09-01 2002-03-13 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivative
EP1334726A4 (en) 2000-10-12 2005-12-14 Chugai Pharmaceutical Co Ltd ERYTHROMYCIN DERIVATIVE WITH NOVEL CRYSTAL STRUCTURES AND METHOD FOR THE PRODUCTION THEREOF
DE60206921T2 (de) 2001-06-13 2006-07-20 Ube Industries, Ltd., Ube Verfahren zur herstellung von erythromycinverbindungen
TW200302830A (en) * 2002-01-11 2003-08-16 Chugai Pharmaceutical Co Ltd Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20040010035A1 (en) * 2002-07-15 2004-01-15 Ciociola Arthur A. Gastrointestinal compositions
WO2004006902A1 (en) * 2002-07-10 2004-01-22 Warner-Lambert Company Llc Combination of an allosteric inhibitor or matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
CN100363359C (zh) * 2002-08-29 2008-01-23 菲塞股份有限公司 运动内酯化合物
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
BRPI0408117A (pt) * 2003-03-05 2006-03-01 Rib X Pharmaceuticals Inc compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
ES2338789T3 (es) 2003-06-18 2010-05-12 Tranzyme Pharma Inc. Antagonistas macrociclicos del receptor de motilina.
US20050113319A1 (en) * 2003-08-26 2005-05-26 Christopher Carreras 11-Deoxy-6,9-ether erythromycin compounds
US7407941B2 (en) * 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
US20070149463A1 (en) * 2003-10-30 2007-06-28 Oyelere Adegboyega K Bifunctional macrolide heterocyclic compounds and methods of making and using the same
EP1699808A1 (en) * 2003-11-18 2006-09-13 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
JP5383037B2 (ja) * 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法
TW200633714A (en) 2004-12-28 2006-10-01 Chugai Pharmaceutical Co Ltd Drugs for the treatment and/or prophylaxis of gastroparesis symptom
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
US8470985B2 (en) 2005-08-24 2013-06-25 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
JP5395432B2 (ja) 2005-08-24 2014-01-22 リブ−エックス ファーマシューティカルズ，インコーポレイテッド トリアゾール化合物ならびにこれを作製する方法および使用する方法
CA2632779A1 (en) * 2005-12-08 2007-06-14 Pfizer Inc. Method for demethylating the 3'-dimethylamino group of erythromycin compounds
EP2054429B1 (en) 2006-09-11 2013-11-06 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
CN101547931B (zh) 2006-12-05 2012-11-14 辉瑞有限公司 促动内酯多晶型
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60218321A (ja) * 1984-04-13 1985-11-01 Satoshi Omura 消化管収縮運動促進剤
JPS6187625A (ja) * 1984-10-05 1986-05-06 Satoshi Omura 消化管収縮運動促進剤
JPH0759513B2 (ja) * 1985-08-31 1995-06-28 北里研究所（社団法人） 消化管収縮運動促進剤
US5008249A (en) * 1985-08-31 1991-04-16 Kitasato Kenkyusho Therapeutic method of stimulating digestive tract contractile motion in mammals
DE3689758T2 (de) * 1985-08-31 1994-08-18 Kitasato Inst Erythromycinderivat und Verfahren zu dessen Herstellung.
EP0623021B1 (en) * 1992-01-21 1998-04-08 Abbott Laboratories 4''-deoxyerythromycin derivatives

Also Published As

Publication number Publication date
AU4089793A (en) 1993-12-30
AU659740B2 (en) 1995-05-25
SI9300281B (en) 2001-02-28
TW240230B (sh) 1995-02-11
HRP930926B1 (en) 2000-10-31
JPH0656873A (ja) 1994-03-01
WO1993024509A1 (en) 1993-12-09
CA2117883A1 (en) 1993-12-09
MY113693A (en) 2002-05-31
DK0643068T3 (da) 1999-02-08
KR100226311B1 (ko) 1999-10-15
SG52785A1 (en) 1998-09-28
US5658888A (en) 1997-08-19
ATE169927T1 (de) 1998-09-15
CN1081184A (zh) 1994-01-26
EP0643068A4 (en) 1995-08-02
DE69320476D1 (en) 1998-09-24
SI9300281A (sl) 1993-12-31
ES2120499T3 (es) 1998-11-01
YU48771B (sh) 1999-12-27
DE69320476T2 (de) 1999-03-25
ZA933679B (en) 1993-12-21
KR950701640A (ko) 1995-04-28
EP0643068A1 (en) 1995-03-15
EP0643068B1 (en) 1998-08-19
CN1036199C (zh) 1997-10-22
IL105810A (en) 1998-12-27
JP3068367B2 (ja) 2000-07-24
HK1009969A1 (en) 1999-09-10
CA2117883C (en) 2003-10-21
IL105810A0 (en) 1993-09-22
HRP930926A2 (en) 1995-02-28

Similar Documents

Publication Publication Date Title
YU36693A (sh) Derivati eritromicina
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
DK306586A (da) Pyridoncarboxylsyre-derivater og fremgangsmaade til fremstilling deraf
NL960012I1 (nl) Gesubstitueerde acylderivaten van 1,2,3,4-tetrahydro-6,7-dimethoxy-3-isochinolinecarbonzuur.
SE8201854L (sv) N-substituerade amino-aminosyror
ATE135709T1 (de) Erythromycinderivate, ihr verfahren zur herstellung und ihre verwendung als arzneimitteln
ES431513A1 (es) Procedimiento para la preparacion de 2 - (heteroaril-metil)-5,9 beta - dialcohil-6,7-benzomorfanos.
KR900018065A (ko) 벤조시클로알칸 유도체 및 그의 제조방법
DE69311118D1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
ES461630A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-(benzazolilalquil)piperidina.
MY101142A (en) 1, 4-dihydropyridine derivative, process for production thereof, and pharmaceutical use thereof.
ES368093A1 (es) Procedimiento para la preparacion de bencilaminas n-hetero-ciclicamente sustituidas.
FR2658821B1 (fr) Nouvelles propanamines, leurs proprietes pharmacologiques et leur application a des fins therapeutiques, notamment antidiarrheuiques.
KR870007169A (ko) 치환 아미드 및 그 산부가염의 제조방법
DE68910090D1 (de) Verwendung heterozyklischer Amide zur Verhinderung der Tumormetastasierung.
DE3685942D1 (de) 2-pyridylessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
FR2665442B1 (fr) Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
GB1232348A (sh)
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.
ES309038A1 (es) Procedimiento para la preparacion de 1, 2, 3, 6, 7, 11 b-hexahidro-4h-pirazino- (2, i-a) -isoquinolinas